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Treating critically ill and high-risk patients
is one of the greatest challenges in medi-
cine, and it is also a multidisciplinary task.
Practice varies country by country result-
ing in a large scatter in outcome data, which
makes the interpretation difficult. Regard-
ing anesthesia and surgery, based on an
international 7 day cohort, the EUSOS-
study, conducted in 28 countries in Europe
including 46,000 patients undergoing inpa-
tient surgery, the overall mortality was 4%,
which was higher than expected (1). What
is even more surprising that 73% of the
patients who died were never admitted to
an intensive care unit (ICU).
One of the leading reasons of an unfa-
vorable outcome is inadequate periopera-
tive hemodynamic management. Although
this statement is widely accepted, yet flu-
ids and catecholamines are commonly pre-
scribed to subjective criteria (2).
Several large prospective randomized
trials have recently studied the effects of
advanced hemodynamic monitoring based
perioperative goal-directed therapy (3–7).
There is also gathering evidence in other
fields of perioperative care that patients
should be treated according to individ-
ualized, physiology based values rather
than guidelines or treatment bundles deter-
mined values (8).
These results may lead to a paradigm
shift in critical care medicine and change
our practice from a protocolized “figure
based” management to treating patients
according to their individual and actual
needs.
FLUID THERAPY AND OUTCOME
The main task of any type of resuscitation
is to maintain adequate balance between
oxygen delivery (DO2) and consumption
(VO2), which is normally around 25–30%
(VO2/DO2) in an awake adult at rest.
Fluid therapy has a pivotal role in main-
taining hemodynamic stability, and it is
important to acknowledge that the only
reason patients need infusion is to nor-
malize DO2 by increasing stroke volume
hence cardiac output (CO). Several stud-
ies revealed that both intraoperative hypo-
and hypervolemia can be responsible for
post-operative complications and organ
failure, while optimization of periopera-
tive hemodynamics may result in improved
outcome (3, 4, 9, 10). Rather than taking
sides on “restrictive” or “liberal” fluid man-
agement, careful monitoring of the hemo-
dynamic status may be more beneficial
in tailoring fluid therapy for the patients’
actual needs.
According to a recent survey, most anes-
thetists rely on conventional measures dur-
ing the management of high-risk patients
(2). However, using heart rate, mean arte-
rial pressure (MAP) and central venous
pressure (CVP) only, to assess the hemo-
dynamic status may be misleading (11, 12).
This conventional approach may be ade-
quate for most patients undergoing sur-
gical procedures, but the relatively small
number of patients at high risk of compli-
cations and even death may need advanced
monitoring guided care. To optimize peri-
operative hemodynamic status of this high-
risk population, the most frequently used
parameters next to standard monitoring
are CO and CO-driven variables, and/or
DO2. CO can be measured by several
ways. The use of intermittent thermodi-
lution by the pulmonary artery catheter
has been decreased in surgical patients
over the past decades, although it may still
have a role in medical patients (13). Less
invasive ways are transpulmonary ther-
modilution or other non-calibrated, pulse
contour analysis based technologies. Fur-
thermore, using non-invasive echocardio-
graphy enables physicians to measure CO,
intravascular pressures and volumes, sys-
tolic and diastolic function of both ventri-
cles, and preload responsiveness. Although
outcome studies are still warranted, but
quick assessment of patients with echocar-
diography on the ICU or monitoring
patients with esophageal Doppler in the
operating theatre can be extremely useful
and becoming more-and-more popular in
the everyday routine (14).
In two recent animal experiments, we
investigated CO and stroke volume guided
hemorrhage and fluid resuscitation in a
porcine model (15, 16). After baseline mea-
surements, animals were bled until cardiac
index (CI) or stroke volume index (SVI)
dropped by 50%, after which animals were
resuscitated over 60 min till baseline CI
and SVI values were reached. In the CI-
group, stroke volume, global end diastolic
volume, and central venous oxygen satu-
ration remained significantly lower, while
stroke volume variation (SVV), central
venous-to-arterial carbon dioxide differ-
ence (dCO2) remained significantly higher
by the end of resuscitation as compared
to baseline, indicating that fluid resus-
citation might had been inadequate and
the normalization of CI was mainly due
to the persistently elevated heart rate,
rather than restoration of the circulat-
ing blood volume. On the contrary in
the SVI group, by the end of resuscita-
tion, SVV, central venous oxygen saturation
(ScvO2), and central venous–arterial car-
bon dioxide gap (dCO2) improved signifi-
cantly or returned to their baseline value
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by the end of the experiment. Based on
these experiments, it seems that the SVI-
based algorithm resulted in better hemo-
dynamic and oxygenation indices as com-
pared to the CI-based approach; how-
ever, it should be tested in a randomized
fashion.
According to the survey by Cannesson
et al., dynamic indices such as SVV, pulse
pressure variation (PPV) are only applied
in 6–25% during anesthesia for high-risk
surgery (2). Heart–lung interactions dur-
ing forced expiration against closed glot-
tis, which was first described by Anto-
nio Mario Valsalva almost 300 years ago,
form the principle of SVV/PPV phenom-
ena. Intermittent positive pressure ven-
tilation can be regarded as a series of
Valsalva-maneuvers: large enough tidal vol-
umes of ~8 mL/kg of ideal bodyweight
(17), will cause decreased venous return,
hence a drop in stroke volume, which can
be detected by SVV/PPV. If the circulation
is well filled the variation is small, while
on the contrary, increased variation means
hypovolemia (Figure 1). It is also impor-
tant to acknowledge that patients have dif-
ferent types of Frank–Starling curves. This
is why set figures of “static” preload indices,
such as CVP, cannot indicate fluid respon-
siveness, also demonstrated in Figure 1
(18). Indeed, the variation in PPV induced
by mechanical ventilation has been shown
to be a very accurate predictor of fluid
responsiveness, with an optimal thresh-
old value around 12% (19). However,
PPV/SVV based approaches have some
limitations: it requires controlled ventila-
tion with tidal volumes above the “pro-
tective” 6 mL/kg tidal volumes, and in the
case of spontaneous breathing or breath-
ing efforts and cardiac arrhythmias values
cannot be relied on.
In a large multicenter randomized
study, we recently reported that a PPV,
MAP, and CI-trending based approach
nearly halved post-operative complications
in high-risk surgical patients undergoing
major abdominal surgery (4). Detailed
analysis revealed that patients undergo-
ing bowel surgery benefited the most from
this intervention, and the only difference
between the treatment and control groups
was that while no patients received posi-
tive inotropic agents in the control group,
but 42% of patients required dobutamine
in the treatment group.
FIGURE 1 | Assessing fluid responsiveness with stroke volume variation (SVV) in patients with
different Frank–Starling curves. The upper curve (——) represents the Frank–Starling curve of a
patient with normal heart, the lower curve ( – – – ) a patient with chronic heart failure. Intermittent
positive pressure ventilation (IPPV) causes a similar changes in ventricular preload (A–B) in both cases.
However, in the patient who is on the flat part on the Frank–Starling curve IPPV causes small stroke
volume variation (SVV1), hence this patient would not respond for fluid administration with an increase
in stroke volume. On the contrary, in the other case, the patient is on the steep part of the curve have
large changes in stroke volume (SVV2), indicating fluid responsiveness.
The results of the OPTIMISE study were
less convincing (5). Seven hundred thirty-
four patients were randomized into control
and CO-guided groups and they found no
significant difference between the groups
in the primary end-point of a compos-
ite outcome of complications and 30-day
mortality. However, there was a measurable
treatment effect, and at 180 days there was
a non-significant reduction in mortality.
In a very recent clinical trial from the
same group, goal directed DO2-therapy
was applied in high-risk surgical patients
needing ICU admission after the opera-
tion (7). Target DO2 was based on the
preoperatively determined individual DO2
values. In the treatment group after the
first hour of optimization 40% of patients
received dobutamine as compared to none
in controls, a very similar result also
reported by us (4). Their main find-
ing was that achievement of preoperative
oxygen delivery soon after major surgery
was associated with a reduction in early
post-operative morbidity, yet this occurred
irrespective of additional post-operative
hemodynamic manipulation. This was in
part due to the fact that more patients
achieved the target DO2 in the control
group (53%) than expected. Their data also
suggest that dobutamine use resulted in
the development of parasympathetic auto-
nomic dysfunction, which can be harmful
and should be investigated in the future.
In the POEMAS study, CO-
measurement based algorithm was applied,
using a non-invasive device (6). Goal
directed therapy was managed accord-
ing to arterial blood pressure, CI, and
stroke volume response. Patients in this
group received significantly more colloid
boluses, red blood cell transfusion, and
more patients required dobutamine (25%).
They observed a significant reduction in
reoperations in the treated group (5.6 vs.
15.7%). However, there were no significant
differences in the overall complications.
It is important to acknowledge that
invasive hemodynamic monitoring based
care is not easy. It takes a lot of time,
effort, and practice to put the data pro-
vided by these monitors into good use (13).
Participants of the research groups may
vary in experience, which can increase the
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noise-to-signal ratio in these trials, which
may explain to some extent the diversity
between the results of these studies. Nev-
ertheless, there is a definitive signal, or at
least a trend, which indicates that hemo-
dynamic stabilization guided by CO and
CO-driven indices could be beneficial in
high-risk patients.
ASSESSING AND TREATING OXYGEN
DEBT
Although global macro-hemodynamic
indices are very important but there is
more to the picture. Another part of this
“hemodynamic puzzle” not to be over-
looked is the assessment of the VO2/DO2
balance. The most often used parameters to
estimate the relationship between oxygen
supply and consumption are mixed venous
saturation (SvO2) and ScvO2. Although
SvO2 is regarded as the most accurate
indicator of the balance between global
VO2/DO2, there is very good evidence
that ScvO2 may serve as an easily obtain-
able and reliable alternative to manage
therapy in critical ill patients (20). Con-
tinuous monitoring of the ScvO2 is also
possible with a device based on fiberop-
tic technology and the measurements
showed good correlation with laboratory
values (21).
It has been shown that following major
surgery reductions in ScvO2 are indepen-
dently associated with post-operative com-
plications (22). In another study, keeping
oxygen extraction ratio below 27% resulted
in less post-operative organ dysfunction
and reduced hospital stay in high-risk sur-
gical patients (23). There is limited data
about the role of ScvO2-guided intra-, and
perioperative management, but it is cer-
tainly something to be investigated in the
future.
Hemoglobin is also one of the main
determinants of DO2. In a number of
guidelines, the indication of blood trans-
fusion is based on certain levels of hemo-
globin, usually 70–100 g/L (24). Higher
values are recommended in patients with
ischemic heart disease, and lower values
for patients without the history of cardiac
dysfunction. However,“ischemic heart dis-
ease” means a wide range as far as severity
can go, while seemingly “healthy” individ-
uals may also have different tolerance of
anemia, therefore this is another scenario
when “one size does not fit all.”
Indeed, in a prospective human inter-
ventional study, it was found that in acute
isovolemic anemia with a hemoglobin of
50 g/L in conscious healthy resting humans
did not produce hemodynamic instabil-
ity, but oxygen imbalance was accompa-
nied by a significant drop in SvO2 (25).
These results were reinforced by a retro-
spective analysis of a prospective observa-
tional study in which ScvO2 was found to
be a good indicator of transfusion (26).
The results of our recent animal study on
isovolemic hemodilution gave further evi-
dence that anemia-induced change in oxy-
gen balance can be monitored by ScvO2
(27). We found that in anesthetized, venti-
lated pigs, low hemoglobin levels were well
tolerated (59 g/L in this case) without oxy-
gen debt. There was also a strong, negative
correlation between VO2/DO2 and ScvO2.
These results suggest that ScvO2 may
help to identify the point when compen-
satory mechanisms become exhausted and
the relationship between VO2/DO2 tips the
balance, hence in the form ScvO2 decision
making in transfusion practice is supported
by a physiological value rather than just
relying on the hemoglobin concentration
alone.
Finally, there has also been a paradigm
shift in severe bleeding management. There
are several new alternatives for improv-
ing outcomes of patients in hemorrhagic
shock, mainly based on the concept of mul-
timodal hemodynamic support and also on
dynamic viscoelastic tests guided individu-
alized coagulation management (28).
It is important to acknowledge
the above mentioned “individualized”
approaches require well trained, experi-
enced personnel. However, in daily reality
patients are often managed by junior staff,
especially after hours. Studies have also
shown that providing additional hemody-
namic information in an everyday setting
does not automatically translate into better
treatment (29). It is for these situations
that simple, “figure driven” protocols have
been introduced in the past.
SUMMARY
There is increasing evidence that inter-
ventions based on multimodal monitoring
of physiological and biochemical processes
in the high-risk patients, let it be in the
perioperative or critical care setting, may
improve outcome. Advanced knowledge
accompanied and reinforced by techni-
cal developments of continuous real time
monitoring of organ function and mol-
ecular mechanisms give firm ground for
utilizing them as a “goal directed indi-
vidualized” approach, which may replace
“figure-driven” protocolized care in the
future.
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